Edgewise Therapeutics, Inc. (EWTX) Net Income by Year
Edgewise Therapeutics, Inc. reported a net loss of $168K in fiscal year 2025. This represents a decrease of 25.4% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Edgewise Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EWTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
EWTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Edgewise Therapeutics, Inc. financials
Frequently Asked Questions
What was Edgewise Therapeutics, Inc.'s net income in fiscal year 2025?
Edgewise Therapeutics, Inc. reported a net loss of $168K in fiscal year 2025.
How fast is Edgewise Therapeutics, Inc.'s net income growing?
Edgewise Therapeutics, Inc. (EWTX) net income fell by 25.4% year over year, from -$134K to -$168K in fiscal year 2025.
How has Edgewise Therapeutics, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Edgewise Therapeutics, Inc. (EWTX) net income went from -$17.1M in fiscal year 2020 to -$168K in fiscal year 2025.
What was Edgewise Therapeutics, Inc.'s net income in the most recent quarter?
Edgewise Therapeutics, Inc. (EWTX) reported -$57.3M in net income in Q2 2026. This represents a decrease of 58.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Edgewise Therapeutics, Inc. (EWTX) reported on that line in every period on record.